These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3524841)

  • 1. Effects of antihypertensive therapy on the hemodynamics of hypertension: clinical implications.
    Lund-Johansen P
    Clin Ther; 1986; 8(4):382-97. PubMed ID: 3524841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between cardiovascular haemodynamics and goals of antihypertensive therapy.
    Lund-Johansen P
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S21-8. PubMed ID: 8487246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential hypertension: hemodynamic and therapeutic changes over 20 years.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S1-7. PubMed ID: 1721971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamics in hypertension: effects of antihypertensive drugs.
    Dupont AG
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S42-5. PubMed ID: 8487249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of resting and effort hemodynamics in essential arterial hypertension using antihypertensive agents].
    Wiechmann HW
    Dtsch Med Wochenschr; 1987 Oct; 112(41):1566-71. PubMed ID: 3665737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
    Lund-Johansen P
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():23-34. PubMed ID: 28190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics in hypertension at rest and during exercise.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S1-5. PubMed ID: 2454353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of different forms of hypertension in childhood].
    Seyberth HW
    Padiatr Padol; 1987; 22(4):365-78. PubMed ID: 3325889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of different antihypertensive combinations].
    Wiechmann HW
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1007-12. PubMed ID: 3289874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.